Skip to content

Escherichia coli susceptibility reporting

E. coli antibiogram software that splits urine from blood and keeps ESBL out of the averages

E. coli is the organism most of your empiric urinary and intra-abdominal guidance rests on. One hospital-wide line that mixes outpatient urine with ICU blood cultures answers neither question well.

Read the short answer

Try the builder on the sample data, or drop in your own CSV. It is parsed in your browser and never uploaded.

Antibiogram Builder
Synthetic sample dataset
Parsed in this browser, never uploaded.

under 40 40 to 59 60 to 74 75 to 89 90 and over n<30, below the reporting threshold n/t, not tested on this panel

Short answer

An E. coli antibiogram reports, for the first isolate per patient, the percent of Escherichia coli susceptible to each drug the lab tests, with the isolate count beside every cell. The useful version splits urine from blood, because nitrofurantoin, fosfomycin and the oral cephalosporins matter for one and ceftriaxone, piperacillin-tazobactam and the carbapenems for the other. Antimicrobe builds it from a lab CSV with no interface and suppresses any cell under 30 isolates. The table with source cuts runs on the Lab plan from $249 a month; unit cuts, quarterly trends and the third generation cephalosporin resistant count are on the Stewardship plan at $749 a month.

Computed from your own isolates, never from a national average.

Why E. coli needs its own report

In most US hospitals E. coli is the most common gram-negative isolate, and the bulk of it comes from urine. That volume is the problem. When a lab publishes a single E. coli row, the outpatient and emergency department cystitis cultures outnumber the bloodstream isolates by ten to one or more, so the hospital-wide ceftriaxone figure mostly describes bladders. A hospitalist choosing empiric therapy for urosepsis, or a surgeon choosing prophylaxis, needs to know what the blood and abdominal isolates do.

The reverse also happens. Committees sometimes drop nitrofurantoin and fosfomycin from the table because they are meaningless for bloodstream infection, and then the emergency department has no local number for the drugs it prescribes most. Splitting by source keeps every drug on the cut where it is used.

  • Urine isolates with nitrofurantoin, fosfomycin, trimethoprim-sulfamethoxazole, cefazolin and the fluoroquinolones
  • Blood isolates with ceftriaxone, cefepime, piperacillin-tazobactam, the carbapenems and the aminoglycosides
  • One isolate per patient per analysis period, so a recurrent UTI patient is not counted six times
  • A count on every cell, and the raw count instead of a percentage below 30 isolates

The thresholds prescribers actually use

E. coli numbers get quoted against fixed cut points. The IDSA guideline on uncomplicated cystitis and pyelonephritis advises against trimethoprim-sulfamethoxazole for empiric cystitis where local resistance exceeds 20 percent, and against an oral fluoroquinolone alone for pyelonephritis where resistance exceeds 10 percent. Those two numbers decide whether the emergency department order set is still right, so the urine cut has to be current and has to come from patients like the ones the order set treats.

Breakpoint history matters too. CLSI lowered the Enterobacterales ceftriaxone breakpoint in 2010, added cefazolin as a surrogate for oral cephalosporins in uncomplicated urinary infection in 2016, and lowered the ciprofloxacin and levofloxacin breakpoints in 2019. A five year trend that crosses one of those years can show a fall in susceptibility that is a rule change, not a change in the bacteria. Antimicrobe reports the interpretation your lab gave each result and keeps the period on every table, so the committee can see where a revision falls.

E. coli report by source, and the decision each cut supports.
Cut Drugs that belong on it Decision it supports Plan
All E. coli, first isolate Every drug tested, with counts Formulary and annual committee review Lab, $249 a month
Urine Nitrofurantoin, fosfomycin, TMP-SMX, cefazolin, ciprofloxacin Cystitis and pyelonephritis order sets Lab, $249 a month
Blood Ceftriaxone, cefepime, piperacillin-tazobactam, meropenem, gentamicin Urosepsis and bacteremia empiric therapy Lab, $249 a month
By unit or ward Same drugs, per location ICU and long stay unit guidance Stewardship, $749 a month
Quarterly trend and 3GC-R count Ceftriaxone resistant share by quarter Spotting ESBL drift before the annual report Stewardship, $749 a month

A worked example from a 180 bed hospital

Take 2,140 E. coli results in a year. After the first isolate rule, 1,412 patients remain: 1,236 urine, 118 blood and 58 from other sources. The single hospital row shows ceftriaxone at 1,264 of 1,412, 89.5 percent, and trimethoprim-sulfamethoxazole at 1,135 of 1,412, 80.4 percent, a resistance rate of 19.6 percent. On that view the urosepsis order set with ceftriaxone looks safe and TMP-SMX sits just under the 20 percent resistance line.

Split by source, the picture changes. Urine ceftriaxone is 1,121 of 1,236, 90.7 percent, but blood ceftriaxone is 97 of 118, 82.2 percent, because the bacteremic patients are older, more often from nursing homes and more often previously treated. Urine TMP-SMX is 976 of 1,236 susceptible, a resistance rate of 21.0 percent, over the IDSA line, because the urine set includes many repeat cystitis patients, so the emergency department cystitis order set should move to nitrofurantoin, which is 1,187 of 1,236 susceptible, 96.0 percent. Filter blood to the ICU and only 26 isolates remain, so the report shows the count and suggests pooling two years. These numbers are illustrative arithmetic, not data from a customer.

How the table is built from your lab export

Your laboratory system exports a line list with patient identifier, collection date, specimen source, unit, organism, drug and the S, I or R result. You upload the CSV and confirm which column is which the first time. Antimicrobe groups the E. coli rows, applies the CLSI M39 first isolate per patient rule, groups specimen sources into urinary, bloodstream and the other syndromes, and builds the cumulative table. No interface project and no IT ticket are needed; the export layout is described on lab information system integration.

The same file gives every other organism, so the E. coli cuts sit beside the Klebsiella antibiogram and the enterococcal rows from Enterococcus antibiogram software. On the Stewardship plan the MDRO watch counts third generation cephalosporin resistant Enterobacterales and CRE by quarter and flags a quarter over the threshold you set, which is the early signal for ESBL drift covered on ESBL antibiogram software.

Who buys this

The buyer is a stewardship pharmacist, emergency department pharmacist or microbiology supervisor who owns the urinary and urosepsis order sets and has been asked whether the local numbers still support them, and who today filters E. coli out of a spreadsheet once a year. The urinary side in more depth is on UTI antibiotic resistance rates, and outpatient and urgent care settings are covered on outpatient antibiogram software. Plans and prices are on the pricing page.

What it does not do

Antimicrobe does not detect ESBL or carbapenemase genes, does not alert on individual patients and does not recommend a dose. It reports what the laboratory resulted, as cumulative tables and trends. Mechanism testing stays in the laboratory, and patient-level alerting belongs to a surveillance platform.

Related reading: hospital antibiogram software, urine antibiogram and UTI resistance rates, ESBL antibiogram software, Klebsiella antibiogram software. The four steps from susceptibility testing data to an antibiogram cover the method end to end.

Questions

On this page's topic

What is an E. coli antibiogram?

It is a cumulative susceptibility report for Escherichia coli showing the percentage of first isolates per patient susceptible to each drug the lab tests, with the isolate count beside every cell. Most hospitals need it split by urine and blood, because the drugs and decisions differ.

Should urine and blood E. coli be reported separately?

Yes, when there are enough isolates. Urine isolates usually outnumber blood isolates many times over, so a combined row reflects cystitis rather than bacteremia. Separate cuts keep nitrofurantoin and fosfomycin on the urine table and give urosepsis therapy its own number.

How many E. coli isolates do you need for an antibiogram?

CLSI M39 recommends at least 30 first isolates per organism for a reliable percentage. Antimicrobe shows the raw count instead of a percentage below that, and you can pool two years of data to reach the threshold for a small cut such as ICU blood.

Does it need an interface to our laboratory system?

No. Your lab exports a susceptibility line list as CSV, you upload it and map the columns once. Most hospitals produce the first E. coli table on the day they start.

More on antimicrobial resistance reporting

  • CLSI breakpoints A breakpoint revision can move a susceptibility rate by several points without one organism...
  • WHONET WHONET is good software, it is free, and it is the global default for a reason. Most US team...
  • TheraDoc competitors Most teams shopping for a TheraDoc alternative are not unhappy with the alerts. They are at...
  • Sentri7 alternatives Sentri7 took two segments in the 2026 Best in KLAS report, so most teams looking for an alte...
  • MedMined alternatives MedMined is now BD HealthSight Infection Advisor, sold next to BD HealthSight Clinical Advis...
  • VigiLanz alternatives VigiLanz is sold by Inovalon in three hospital tiers now, and the antibiogram sits in the to...

Start with your own export

See your own resistance picture, cut the way you actually work

Build the antibiogram on the synthetic sample dataset, or drop in your own CSV and watch it parse without leaving your browser. When you want an account, one email address is the whole sign-up.

Your file is parsed in your browser and never uploaded. No card required.